Taiwan FDA registration 5fae966a14222fbd1245cac7d2009fe3
Baijie ovarian cancer antigen 125 enzyme immunoassay group
TW: 佰杰卵巢癌抗原125酵素免疫分析組
Taiwan·Risk Class 2·BIOCHECK, INC.·Registered Dec 13, 2006 – Dec 13, 2011CancelledRegistration details
- Analysis ID
- 5fae966a14222fbd1245cac7d2009fe3
- Customs Code
- DHA00601783309
Company information
- Manufacturer
- BIOCHECK, INC.
- Manufacturer Country
- United States
- Authorized Representative
- GENERAL BIOLOGICALS CORP.
Product details
- Intended Use
- It is used for the quantitative analysis of serum turbidity of tumor antigen CA125.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.6010 腫瘤相關抗原免疫試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Dec 13, 2006
- Expiry Date
- Dec 13, 2011
- Cancellation Date
- May 05, 2014
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Baijie ovarian cancer antigen 125 enzyme immunoassay group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5fae966a14222fbd1245cac7d2009fe3 and manufactured by BIOCHECK, INC.. The authorized representative in Taiwan is GENERAL BIOLOGICALS CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices